Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
Findings suggest that racemic substitution for single-enantiomer drugs offers an opportunity for savings.
Each hospital and health system—and insurer—has unique circumstances, but there are several common approaches that are likely to help curb the growth in drug costs.
Reference pricing models are emerging as increasingly popular approaches for lowering drug costs.
To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive conducted its annual pharmacy survey during the first quarter of 2018.
To get a pulse on the U.S.
Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.
Last year was a banner year for generic drug approvals by the FDA. Find out what’s in store for 2017.